Shehnaaz Suliman

Director · 10x Genomics

Shehnaaz Suliman (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in 10x Genomics, Inc. (TXG). The largest single filing was $393K of TXG (4,817 sh across 3 lots, as filed), executed Sep 22. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$817K

shares × price, as filed

Last traded

Sep 22

Filed Sep 24

Median ADV $190.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $817K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

TXG

10x Genomics, Inc. TXG · 0 buys · 3 sells 3 filings RARE

Ultragenyx Pharmaceutical Inc. RARE · 0 buys · 1 sell 1 filing

Recent filings

TXGSALE 10x Genomics, Inc. View filing → $393K
4,817 sh across 3 lots
Exec Sep 22
Filed Sep 24 · 4:30 PM ET TXGSALE 10x Genomics, Inc. View filing → $105K
1,646 sh × $63.97
Exec Aug 24
Filed Aug 26 · 4:42 PM ET TXGSALE 10x Genomics, Inc. View filing → $175K
5,359 sh × $32.59
Exec Jun 16
Filed Jun 18 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. View filing → $144K
5,740 sh × $25.12
Exec May 18
Filed May 18 · 5:30 PM ET